2019 annual financial data
Tango Therapeutics 2019 Operating margin
Tango Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -61.51%.
Operating income was -15,162,000 USD and net income was -14,095,000 USD.
Operating cash flow was -24,803,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,649,000 USD
- Operating income
- -15,162,000 USD
- Net income
- -14,095,000 USD
- Operating cash flow
- -24,803,000 USD